Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using hydrofluoroether solvents to replace HCFC-141b, Part II.

F Govaerts1, D D Keane

  • 13M Belgium, N.V., Zwijndrecht, Belgium. fgovaerts1@mmm.com

Medical Device Technology
|August 27, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using hydrofluoroether solvents to replace HCFC-141b, Part I.

Medical device technology·2003
Same author

Advice on healthy food as given by Flemish general practitioners.

The American journal of clinical nutrition·1997
Same author

The thyroxine-stimulating activity is only present in the glycoprotein and not in the protein fraction of a carp hypophyseal homogenate.

General and comparative endocrinology·1986
Same author

[Leisure time under a masculinistic regime].

L' Infirmiere canadienne·1973
Same author

Measurement of glomerular filtration in humans by intravenous glucose injection.

Bruxelles medical·1948
Same journal

Safer arterial access.

Medical device technology·2010
Same journal

Building better surfaces.

Medical device technology·2010
Same journal

PVC: a broader perspective.

Medical device technology·2010
Same journal

Joining and forming using torsional ultrasonic principles.

Medical device technology·2010
Same journal

US regulation of combination products.

Medical device technology·2010
Same journal

Assessing biological safety of metals associated with medical devices.

Medical device technology·2010
See all related articles

Hydrochlorofluorocarbon (HFC) solvents are banned, prompting the search for replacements like hydrofluoroethers. This study evaluates their benefits and explores cost-reduction strategies for transitioning away from HFCs.

Area of Science:

  • Environmental Chemistry
  • Industrial Chemistry
  • Green Chemistry

Background:

  • Hydrochlorofluorocarbon (HFC) solvents face a regulatory ban effective end-of-2001.
  • The industry requires viable alternatives to HFCs for solvent applications.
  • Existing alternatives may present cost challenges for widespread adoption.

Purpose of the Study:

  • To assess the suitability and advantages of hydrofluoroethers (HFEs) as HFC replacement solvents.
  • To investigate methods for mitigating the economic impact of transitioning to alternative solvents.
  • To provide guidance on cost-effective solvent replacement strategies.

Main Methods:

  • Evaluation of hydrofluoroether properties and performance characteristics.
  • Economic analysis of conversion costs associated with HFC alternatives.

Related Experiment Videos

  • Exploration of strategies to reduce the financial burden of solvent substitution.

    • Main Results:

    • Hydrofluoroethers demonstrate potential as effective replacements for banned HFC solvents.
    • The initial cost of alternative solvents is higher than that of HFCs.
    • Specific strategies can be employed to lower the overall cost of conversion.

    Conclusions:

    • Hydrofluoroethers present a technically feasible, albeit initially more expensive, alternative to HFCs.
    • Implementing targeted cost-reduction measures is crucial for successful HFC phase-out.
    • Further research into cost-effective implementation of HFEs is warranted.